Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review
- PMID: 32359452
- PMCID: PMC8152573
- DOI: 10.1016/S2352-3026(20)30064-8
Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review
Abstract
In children who receive neurotoxic chemotherapy, peripheral neurotoxicity occurs frequently, necessitates dose reduction or treatment cessation, and affects function and long-term quality of life. No treatments exist for peripheral neurotoxicity and few assessment measures are specific to children. We did a systematic review to analyse the published literature concerning the evaluation of assessment measures for paediatric chemotherapy-induced peripheral neurotoxicity. We searched PubMed, CINAHL, PsycINFO, and Embase on Nov 7-8, 2018; of 1409 articles, seven met the inclusion criteria. A total of 335 children (excluding ten healthy controls) were enrolled in the seven studies and the sample sizes ranged from 17 to 86 individuals. 276 (82%) of the 335 children were actively undergoing chemotherapy treatment. Most studies did not comprehensively evaluate the psychometric properties of assessment measures for chemotherapy-induced peripheral neurotoxicity. By use of a narrative analysis that combined approaches from the Joanna Briggs Institute (Adelaide, SA, Australia) and the quality of diagnostic accuracy studies assessment method (known as QUADAS), only one study was deemed high quality. We identified two variants of the Total Neuropathy Score, two grading scales, two semi-objective tests, one patient-reported outcome, and several mobility measures. The National Cancer Institute Common Terminology Criteria for Adverse Events and the Balis grading scales showed lower sensitivity and specificity than the items of the Total Neuropathy Score. Although there is insufficient evidence to support the use of most approaches to assess chemotherapy-induced peripheral neurotoxicity in children, two variants of the Total Neuropathy Score, the pediatric-modified Total Neuropathy Score and the Total Neuropathy Score-pediatric vincristine, are promising but require further testing. Other approaches are less sensitive or less feasible. A patient-reported outcome measure for chemotherapy-induced peripheral neurotoxicity in children is needed.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests
We declare no competing interests.
Figures
Similar articles
-
The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers.Support Care Cancer. 2013 Mar;21(3):847-56. doi: 10.1007/s00520-012-1591-8. Epub 2012 Sep 20. Support Care Cancer. 2013. PMID: 22993026
-
Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.JAMA Neurol. 2018 Aug 1;75(8):980-988. doi: 10.1001/jamaneurol.2018.0963. JAMA Neurol. 2018. PMID: 29799906 Free PMC article.
-
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity.Neurology. 2021 Aug 17;97(7):e660-e672. doi: 10.1212/WNL.0000000000012300. Epub 2021 Jun 2. Neurology. 2021. PMID: 34078718 Free PMC article.
-
The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.Oncol Nurs Forum. 2008 Jan;35(1):96-102. doi: 10.1188/08.ONF.96-102. Oncol Nurs Forum. 2008. PMID: 18192158 Review.
-
Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity.J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S13-S25. doi: 10.1111/jns.12333. J Peripher Nerv Syst. 2019. PMID: 31647154 Review.
Cited by
-
Vincristine-Induced Peripheral Neuropathy in Children With Malignancy and the Effect of Missed Doses on Treatment Success.Cureus. 2023 Sep 27;15(9):e46063. doi: 10.7759/cureus.46063. eCollection 2023 Sep. Cureus. 2023. PMID: 37771936 Free PMC article.
-
The Effect and Safety of Olanzapine on Nausea and Vomiting in Children Receiving Moderately Emetogenic Chemotherapy.Adv Biomed Res. 2023 Jun 28;12:158. doi: 10.4103/abr.abr_356_22. eCollection 2023. Adv Biomed Res. 2023. PMID: 37564446 Free PMC article.
-
Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).Cancer Med. 2023 Oct;12(19):19480-19490. doi: 10.1002/cam4.6550. Epub 2023 Sep 21. Cancer Med. 2023. PMID: 37732486 Free PMC article. Clinical Trial.
-
Assessment measures for chemotherapy-induced peripheral neuropathy among pediatric oncology patients: an updated systematic review.Support Care Cancer. 2025 May 29;33(6):514. doi: 10.1007/s00520-025-09515-5. Support Care Cancer. 2025. PMID: 40442349 Free PMC article. Review.
-
Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.Cancers (Basel). 2022 Jul 19;14(14):3510. doi: 10.3390/cancers14143510. Cancers (Basel). 2022. PMID: 35884569 Free PMC article.
References
-
- Kandula T, Park SB, Cohn RJ, Krishnan AV, Farrar MA. Pediatric chemotherapy induced peripheral neuropathy: a systematic review of current knowledge. Cancer Treat Rev 2016; 50: 118–28. - PubMed
-
- Tay CG, Lee VWM, Ong LC, Goh KJ, Ariffin H, Fong CY. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer 2017; 64: e26471. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous